Co-Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Co-Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10360
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit. Its products finds application in window period detection in blood screening, viral load for monitoring the success of treatment, and infant diagnosis for detecting disease in infants, among others. The company’s technologies comprise Co-Dx, a suite of mathematically-engineered DNA-based polymerase chain reaction diagnostics products, and Adaptivex which helps primers address the challenge of unexpected mutations. Its technology is designed for new generation mobile point-of-care diagnostic devices, and commercially available devices. Co-Diagnostics is headquartered in Sandy, Utah, the US.

Co-Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Co-Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Co-Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Co-Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Co-Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Co-Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Co-Diagnostics Inc, Medical Equipment, Deal Details 11
Asset Purchase 11
Co-Diagnostics To Acquire Additional PCR Primer Tech From DNA Logix 11
Co-Diagnostics Completes Acquisition Of Genetic Analysis Technologies From DNA Logix 12
Venture Financing 13
Co-Diagnostics Raises USD0.8 Million in Venture Financing 13
Partnerships 14
Biosearch Technologies Enters into Licensing Agreement with Co-Diagnostics 14
Biosearch Enters into Licensing Agreement with Co-Diagnostics 15
Lab21 Enters Into Licensing Agreement With Cooperative Diagnostics 16
Co-Diagnostics Forms Joint Venture With DNA Logix 17
Equity Offering 18
Co-Diagnostics Plans to Raise up to USD25 Million in Public Offering of Securities 18
Co-Diagnostics to Raise up to USD8.7 Million in IPO 19
Debt Offering 20
Co-Diagnostics Raises USD2 Million in Private Placement of Debt instruments 20
Asset Transactions 21
Co-Diagnostics To Acquire Additional PCR Primer Tech From DNA Logix 21
Co-Diagnostics Completes Acquisition Of Genetic Analysis Technologies From DNA Logix 22
Co-Diagnostics Inc – Key Competitors 23
Co-Diagnostics Inc – Key Employees 24
Co-Diagnostics Inc – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 25
Recent Developments 26
Strategy And Business Planning 26
Nov 07, 2017: Co-Diagnostics Manufacturing Joint Venture Breaks Ground in India 26
Financial Announcements 27
Nov 15, 2017: Co-Diagnostics Reports Q3 Financial Results and Updates Corporate Developments 27
Legal and Regulatory 28
Nov 02, 2017: Co-Diagnostics Granted ISO 13485:2016 Certification 28
Product News 29
Oct 10, 2018: Co-Diagnostics receives patent for CoPrimer technology 29
Jun 11, 2018: Co-Diagnostics to Host Booth at CARPHA Conference 30
Jun 05, 2018: Co-Diagnostics Announces Advancement of Co-Primers Technology in Multiplex SNP Genotyping 31
Jun 01, 2018: Co-Diagnostics Announces Participation in Research Project with Stanford University 32
Feb 28, 2018: Co-Diagnostics Announces Positive Results from Co-Primers Technology in Multiplex Tests for SNP Detection 33
Feb 21, 2018: Co-Diagnostics Ships Product to India for Validation Study 34
Other Significant Developments 35
Mar 22, 2018: Co-Diagnostics Announces Construction Update at JV Manufacturing Facility in India 35
Dec 19, 2017: Co-Diagnostics Enters Into Lease for New, Upgraded Laboratory Facility 36
Sep 05, 2017: Co-Diagnostics to Sign Purchase Agreement with MEDCIS Pathlabs 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Co-Diagnostics Inc, Medical Equipment, Key Facts 2
Co-Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Co-Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Co-Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Co-Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Co-Diagnostics Inc, Deals By Market, 2012 to YTD 2018 9
Co-Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Co-Diagnostics To Acquire Additional PCR Primer Tech From DNA Logix 11
Co-Diagnostics Completes Acquisition Of Genetic Analysis Technologies From DNA Logix 12
Co-Diagnostics Raises USD0.8 Million in Venture Financing 13
Biosearch Technologies Enters into Licensing Agreement with Co-Diagnostics 14
Biosearch Enters into Licensing Agreement with Co-Diagnostics 15
Lab21 Enters Into Licensing Agreement With Cooperative Diagnostics 16
Co-Diagnostics Forms Joint Venture With DNA Logix 17
Co-Diagnostics Plans to Raise up to USD25 Million in Public Offering of Securities 18
Co-Diagnostics to Raise up to USD8.7 Million in IPO 19
Co-Diagnostics Raises USD2 Million in Private Placement of Debt instruments 20
Co-Diagnostics To Acquire Additional PCR Primer Tech From DNA Logix 21
Co-Diagnostics Completes Acquisition Of Genetic Analysis Technologies From DNA Logix 22
Co-Diagnostics Inc, Key Competitors 23
Co-Diagnostics Inc, Key Employees 24
Co-Diagnostics Inc, Subsidiaries 25
Co-Diagnostics Inc, Joint Venture 25

List of Figures
Co-Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Co-Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Co-Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Co-Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Co-Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Co-Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Co-Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Co-Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Co-Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Novavax Inc (NVAX):製薬・医療:M&Aディール及び事業提携情報
    Summary Novavax Inc (Novavax) is a clinical-stage biotechnology company that focuses on the discovery, development and commercialization of vaccines to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccine …
  • Accelerate Diagnostics Inc (AXDX):企業の財務・戦略的SWOT分析
    Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Clarivate Plc (CLVT):企業の財務・戦略的SWOT分析
    Clarivate Plc (CLVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Domainex Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Domainex Ltd (Domainex) is a drug discovery service company that offers drug discovery programmes against a wide range of drug targets. The company provides services such as molecular biology / cdh, protein expression, assays, fragment screening, virtual screening, computational chemistry, m …
  • Voith Hydro Holding GmbH & Co KG:企業の戦略的SWOT分析
    Voith Hydro Holding GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • RAK Petroleum Plc (RAKP):企業の財務・戦略的SWOT分析
    Summary RAK Petroleum Plc (RAK Petroleum), a subsidiary of RAK Investment Auhtority, is oil and gas company that transports and trades oil, gas and petrochemicals. The company carries out upstream, midstream and downstream activities. It operates its projects in the Middle East and Africa. RAK Petro …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • BASF Corp:企業の戦略的SWOT分析
    BASF Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Lonestar Resources US, Inc. (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Magnetek Inc:企業の戦略的SWOT分析
    Magnetek Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Virgin Money PLC:企業の戦略的SWOT分析
    Virgin Money PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • CBR Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CBR Systems Inc (CBR), a subsidiary of AMAG Pharmaceuticals Inc, is a stem cell company that offers new born stem cells. The company provides collection, processing, and long-term cryopreservation services for newborn umbilical cord blood stem cells and cord tissue units. It offers cord bloo …
  • Graphic Packaging Holding Company:企業の戦略・SWOT・財務分析
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Taewoong Medical Co Ltd:企業の製品パイプライン分析2018
    Summary Taewoong Medical Co Ltd (Taewoong Medical) is a medical device company that develops and manufactures stents and other medical devices. The company offers products such as self-expandable metal stent, endoscopic RFA, endoscopic accessory, ureteral stent, airway stent, colonic stent, surgical …
  • Corpak MedSystems Inc-医療機器分野:企業M&A・提携分析
    Summary Corpak MedSystems Inc (Corpak), a subsidiary of Halyard Health Inc is a medical device company that manufactures and markets enteral feeding safety devices. The company offers products such as cortrak systems, gastrostomy, nasoenteric systems, gastric decompression, NICU products and accesso …
  • Emerson Electric Co (EMR)-エネルギー分野:企業M&A・提携分析
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • Marubeni Corporation:企業の戦略・SWOT・財務分析
    Marubeni Corporation - Strategy, SWOT and Corporate Finance Report Summary Marubeni Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Achaogen Inc (AKAO)-製薬・医療分野:企業M&A・提携分析
    Summary Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company is developing plazomicin for the treatment of serious bacterial infections due to MDR E …
  • JPMorgan Chase & Co (JPM):企業の財務・戦略的SWOT分析
    JPMorgan Chase & Co (JPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆